Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Current Leases (2022 - 2025)

Cellebrite DI's Current Leases history spans 4 years, with the latest figure at $4.0 million for Q4 2025.

  • Quarterly Current Leases fell 3.13% to $4.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.0 million through Dec 2025, down 3.13% year-over-year, with the annual reading at $4.0 million for FY2025, 3.13% down from the prior year.
  • Current Leases came in at $4.0 million for Q4 2025, down from $17.8 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $18.1 million in Q2 2025 to a low of $4.0 million in Q4 2025.
  • The 4-year median for Current Leases is $7.3 million (2023), against an average of $8.4 million.
  • The largest YoY upside for Current Leases was 152.9% in 2025 against a maximum downside of 21.17% in 2025.
  • Cellebrite DI's Current Leases stood at $5.0 million in 2022, then decreased by 0.62% to $5.0 million in 2023, then decreased by 17.04% to $4.1 million in 2024, then dropped by 3.13% to $4.0 million in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Current Leases are $4.0 million (Q4 2025), $17.8 million (Q3 2025), and $18.1 million (Q2 2025).